Elanco Animal Health is an American pharmaceutical company that develops and produces products for animal health. The company was founded in 1954 and is headquartered in Greenfield, Indiana. Elanco produces a wide range of products for both livestock and pets, including vaccines, antibiotics, and parasiticides. The company operates in more than 90 countries and has a global workforce of over 5,500 employees. Elanco was spun off from Eli Lilly and Company in 2018 and became a publicly traded company in September of that year. The company is listed on the New York Stock Exchange under the ticker symbol ELAN.